MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the …
MGX investors have a unique opportunity to participate in a securities fraud lawsuit against Metagenomi, Inc. with the Schall Law Firm. The Schall Law Firm, a well-known national shareholder rights litigation firm, has filed a class-action lawsuit against Metagenomi, Inc. (NASDAQ: MGX) for violations of federal securities laws.
The lawsuit specifically targets investors who purchased Metagenomi’s securities during the company’s initial public offering (IPO) on February 9, 2024. If you fall into this category and have incurred losses, don’t hesitate to reach out to the Schall Law Firm before November 25, 2024. By participating in the lawsuit, you can seek to recover your losses and protect your rights as a shareholder.
The lawsuit alleges that Metagenomi made false and misleading statements throughout the IPO period regarding its business relationship with Moderna. Despite claiming a strong collaboration and licensing agreement with Moderna, the company later announced the termination of this partnership, leading to significant investor losses.
To learn more about how you can participate in the lawsuit and potentially recover your losses, contact Brian Schall of the Schall Law Firm at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or by phone at 310-301-3335. You can also visit the firm’s website at www.schallfirm.com, or email Brian directly at bschall@schallfirm.com.
Remember, until the class is certified, taking action is crucial to ensure you are represented. Don’t miss this opportunity to hold Metagenomi accountable and protect your investments. Call the Schall Law Firm today to discuss your rights free of charge.
